Nadia H. Agha

Nadia H. Agha

Auto-generated profile, based on publicly available information

Nadia H. Agha

Baylor College of Medicine 1 Department of Integrative Physiology Houston, TX

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
CLChang Seok Lee
Chang Seok Lee
SJSung Yun Jung
Sung Yun Jung
RYRachel Sue Zhen Yee
Rachel Sue Zhen Yee
NANadia H. Agha
Nadia H. Agha
JHJin Hong
Jin Hong
SHSusan L. Hamilton
Susan L. Hamilton
Here we show that striated muscle preferentially expressed protein kinase α (Spegα) maintains cardiac function in hearts with Spegβ deficiency. Speg is required for stability of excitation-contraction coupling (ECC) complexes and interacts with esterase D (Esd), Cardiomyopathy-Associated Protein 5 (Cmya5), and Fibronectin Type III and SPRY Domain Containing 2 (Fsd2) in cardiac and skeletal muscle. Mice with a sequence encoding a V5/HA tag inserted into the first exon of the Speg gene (HA-Speg mice) display a >90% decrease in Spegβ but Spegα is expressed at ~50% of normal levels. Mice deficient in both Spegα and Speg β (Speg KO mice) develop a severe dilated cardiomyopathy and muscle weakness and atrophy, but HA-Speg mice display mild muscle weakness with no cardiac involvement. Spegα in HA-Speg mice suppresses Ca2+ leak, proteolytic cleavage of Jph2, and disruption of transverse tubules. Despite it’s low levels, HA-Spegβ immunoprecipitation identified Esd, Cmya5 and Fsd2 as Spegβ binding partners that localize to triads and dyads to stabilize ECC complexes. This study suggests that Spegα and Spegβ display functional redundancy, identifies Esd, Cmya5 and Fsd2 as components of both cardiac dyads and skeletal muscle triads and lays the groundwork for the identification of new therapeutic targets for centronuclear myopathy.

1 November 2020 in Acta Astronautica
Verified
Journal Article
Closed access
ALAlice D. LaGoy
Alice D. LaGoy
ASAaron M. Sinnott
Aaron M. Sinnott
MAMikayla Ambarian
Mikayla Ambarian
GPGert-Jan Pepping
Gert-Jan Pepping
EKEmmanuel Katsanis
Emmanuel Katsanis
CCChristopher Connaboy
Christopher Connaboy

1 March 2021 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
RARod J. Azadan
Rod J. Azadan
NANadia H. Agha
Nadia H. Agha
HKHawley E. Kunz
Hawley E. Kunz
Forrest BakerForrest Baker
Forrest Baker
PMPreteesh L. Mylabathula
Preteesh L. Mylabathula
EKEmmanuel Katsanis
Emmanuel Katsanis

11 December 2024 in Journal of General Physiology
Verified
Journal Article
Open access
AHAmy D. Hanna
Amy D. Hanna
TCTing Chang
Ting Chang
KHKevin Ho
Kevin Ho
RYRachel Sue Zhen Yee
Rachel Sue Zhen Yee
WWWilliam Cameron Walker
William Cameron Walker
SHSusan L. Hamilton
Susan L. Hamilton
Dilated cardiomyopathy (DCM) is a highly prevalent and genetically heterogeneous condition that results in decreased contractility and impaired cardiac function. The FK506-binding protein FKBP12 has been implicated in regulating the ryanodine receptor in skeletal muscle, but its role in cardiac muscle remains unclear. To define the effect of FKBP12 in cardiac function, we generated conditional mouse models of FKBP12 deficiency. We used Cre recombinase driven by either the α-myosin heavy chain, (αMHC) or muscle creatine kinase (MCK) promoter, which are expressed at embryonic day 9 (E9) and E13, respectively. Both conditional models showed an almost total loss of FKBP12 in adult hearts compared with control animals. However, only the early embryonic deletion of FKBP12 (αMHC-Cre) resulted in an early-onset and progressive DCM, increased cardiac oxidative stress, altered expression of proteins associated with cardiac remodeling and disease, and sarcoplasmic reticulum Ca2+ leak. Our findings indicate that FKBP12 deficiency during early development results in cardiac remodeling and altered expression of DCM-associated proteins that lead to progressive DCM in adult hearts, thus suggesting a major role for FKBP12 in embryonic cardiac muscle.